UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 40

of 'Systemic therapy for advanced non-small cell lung cancer with an activating mutation in the epidermal growth factor receptor'

40
TI
MET amplification (amp) as a resistance mechanism to osimertinib
AU
Piotrowska Z, Thress KS, Mooradian M, et al
SO
J Clin Oncol. 2017;35S(15):ASCO #9020.
 
AD